刘灏 林智琪 符方勇 周忠信 刘正军.抗IFITM1 单克隆抗体的制备及检测[J].,2014,14(9):1606-1610 |
抗IFITM1 单克隆抗体的制备及检测 |
Preparation and Application ofA Monoclonal AntibodyAgainst IFITM1 |
|
DOI: |
中文关键词: 干扰素诱导的跨膜蛋白-1 结肠癌 单克隆抗体 |
英文关键词: Interferon-induced transmembrane protein 1 Colon cancer Monoclonal antibody |
基金项目:国家自然科学基金面上项目(81172383);广东省自然科学基金资助博士启动项目(S2011040002946) |
|
摘要点击次数: 900 |
全文下载次数: 1024 |
中文摘要: |
目的:制备抗干扰素诱导的跨膜蛋白-1(interferon-induced transmembrane protein 1, IFITM1)的单克隆抗体,为检测IFITM1
及进一步研究其在结肠肿瘤发生过程中的作用提供实验基础。方法:以结肠癌患者的癌组织为材料,提取总RNA,以RT-PCR扩
增得到IFITM1 cDNA 序列,经ECoRⅠ和HindⅢ双酶切后,克隆入pGEX-4T-3 进行原核表达并纯化得IFITM1-GST;以该融合蛋
白免疫BALB/c 小鼠,淋巴细胞杂交瘤法制备单克隆抗体;采用ELISA、Western-blot及免疫组织化学法以制备的抗体检测结肠癌
患者结肠癌组织中的IFITM1。结果:成功构建了IFITM1 原核表达载体,获得了IFITM1-GST 重组蛋白;制备得到了1 株抗
IFITM1 单克隆抗体,腹水ELISA 效价为1:30000,抗体亚类为IgG1,可用于ELISA、Western-blot及免疫组织化学法检测结肠癌患
者结肠癌组织中的IFITM1。结论:获得了1 株可用于ELISA、Western-blot及免疫组织化学法的抗IFITM1 单克隆抗体2F-1,为进
一步研究IFITM1在结肠肿瘤发生过程中的作用提供了实验基础。 |
英文摘要: |
Objective:To prepare a monoclonal antibody (mAb) against IFITM1 and provide experimental basis for the detection
of IFITM1 and explore the role of IFITM1 in the development of colorectal cancer.Methods:Total RNA was extracted from colonic
cancer cells collected from a patient with colon cancer. RT-PCR was performed to obtain the cDNA of IFITM1. After double digested
with EcoRⅠ and Hind Ⅲ, the cDNA of IFITM1 was cloned into pGEX-4T-3 vector and transformed into E.coli BL21 cells for fusion
IFITM1-GST expression. For the generation of monoclonal antibodies against IFITM1, the BALB/c mice were immunized with
IFITM1-GST, and the hybridoma techniques were employed. Then, we determine whether the mAbs could be applied to ELISA,
Western-blot and immunohistochemistry for the detection of IFITM1 in the cancer tissues from colon cancer patients.Results:A
recombinant plasmid with target gene and expressed recombinant IFITM1-GST in was successfully constructed. One hybridoma
cell line secreting anti-IFITM1 mAb 2F-1 belonged to IgG1 was obtained. The ELISA titer of ascetic fluids was 3× 10-4. mAb 2F-1 could
be applied to Western-blot, ELISA and immunohistochemistry for the detection of IFITM1 in the cancer tissues from colon cancer
patients.Conclusion:A monoclonal antibody that could be applied to Western-blot for the detection of IFITM1 in the sera or the cancer
tissues from colon cancer patie nts was successfully generated, which provided a new approach for the study of IFITM1 functions in the
origination and development of colon cancer. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |